PDB 5cmu
PDB Information
PDB | 5CMU |
Method | X-RAY DIFFRACTION |
Host Organism | Escherichia coli |
Gene Source | Human immunodeficiency virus 1 |
Primary Citation | Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide Strategy.
Sci Rep
|
Header | Viral Protein |
Released | 2015-07-17 |
Resolution | 2.110 |
CATH Insert Date | 27 Sep, 2015 |
PDB Images (7)
PDB Prints
PDB Chains (3)
Chain ID | Date inserted into CATH | CATH Status |
---|---|---|
A | 28 Sep, 2015 | Chopped |
B | 28 Sep, 2015 | Chopped |
C | 28 Sep, 2015 | Chopped |
CATH Domains (3)
Domain ID | Date inserted into CATH | Superfamily | CATH Status |
---|---|---|---|
5cmuA00 | 30 Sep, 2015 | 1.10.287.210 | Assigned |
5cmuB00 | 01 Oct, 2015 | 1.10.287.210 | Assigned |
5cmuC00 | 01 Oct, 2015 | 1.10.287.210 | Assigned |
UniProtKB Entries (3)
Accession | Gene ID | Taxon | Description |
---|---|---|---|
P04578 | ENV_HV1H2 | HIV-1 M:B_HXB2R | Envelope glycoprotein gp160 |
P04578 | ENV_HV1H2 | HIV-1 M:B_HXB2R | Envelope glycoprotein gp160 |
P04578 | ENV_HV1H2 | HIV-1 M:B_HXB2R | Envelope glycoprotein gp160 |